Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGM-CSF for Chemoradiotherapy-induced Oral Mucositis in Nasopharyngeal Carcinoma
NCT01806272Phase 2Unknown
- Start
- Mar 2013
- Primary completion
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in oral mucositis (OM). Status: unknown.
02
Drugs
sargramostim
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT01806272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01806272.